Publications in collaboration with researchers from Hospital Universitario Central de Asturias (35)

2024

  1. Analysis of the Evolution of Tuberculosis in Men and Women in Spain Between 2017 and 2022. Is There a Different Incidence Decline by Gender?

    Archivos de Bronconeumologia, Vol. 60, Núm. 5, pp. 312-315

  2. Highlights 57th SEPAR Congress

    Open Respiratory Archives, Vol. 6, Núm. 4

2023

  1. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

  2. Highlights of the 55th SEPAR Congress

    Open Respiratory Archives, Vol. 5, Núm. 1

  3. Influence on sputum microbiology with CFTR modulator (tezacaftor-ivacaftor) in adult patients with cystic fibrosis: Multicenter study

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 3, pp. 193-195

  4. SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge

    Pediatric Pulmonology, Vol. 58, Núm. 11, pp. 3195-3205

2022

  1. Discriminant Validity of a Single Clinical Question for the Screening of Inactivity in Individuals Living with COPD

    International journal of chronic obstructive pulmonary disease, Vol. 17, pp. 3033-3044

  2. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21

  3. Real Life With Tezacaftor and Ivacaftor in Adult Patients With Cystic Fibrosis: Spanish Multicenter Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 9, pp. 672-674

2021

  1. Study of the Diagnostic Delay of Tuberculosis in Spain

    Archivos de Bronconeumologia

2020

  1. Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 56, Núm. 9, pp. 551-558

  2. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial

    The Lancet Respiratory Medicine, Vol. 8, Núm. 4, pp. 359-367

  3. Factors Associated With Extrapulmonary Tuberculosis in Spain and Its Distribution in Immigrant Population

    Open Respiratory Archives, Vol. 2, Núm. 3, pp. 119-126

  4. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

    Respiratory Medicine, Vol. 170

  5. Study of the Diagnostic Delay of Tuberculosis in Spain

    Archivos de Bronconeumologia

  6. Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020

    Emerging Infectious Diseases, Vol. 26, Núm. 11, pp. 2709-2712

2018

  1. Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis

    Respiration, Vol. 96, Núm. 5, pp. 406-416

2017

  1. A simple algorithm for the identification of clinical COPD phenotypes

    European Respiratory Journal, Vol. 50, Núm. 5

  2. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341

  3. Individual patterns of complexity in cystic fibrosis lung microbiota, including predator bacteria, over a 1-year period

    mBio, Vol. 8, Núm. 5